The SA Health Products Regulatory Authority (Sahpra) said on Tuesday it had approved a “section 21” emergency use application for the Covid-19 vaccine developed by Pfizer and BioNTech.
The country’s drugs regulator said the approval was subject to further efficacy and safety surveillance of the vaccine in the country, including against the dominant local coronavirus variant.
- Reuters
Would you like to comment on this article or view other readers' comments? Register (it’s quick and free) or sign in now.
Please read our Comment Policy before commenting.